PACTR202404502445612招募中Unknown
Study of the efficacy of Ceftaroline in the management of pediatric severe sepsis and septic shock
Pediatric department Faculty of Medicine Alexandria University0 个研究点目标入组 46 人开始时间: 2024年4月9日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 Month(s) 至 23 Month(s)（—）
- 性别
- All
入选标准
- •Severe sepsis or septic shock as defined by The Surviving Sepsis Campaign (SSC) guidelines 2020.
排除标准
- •- Severe immunodeficiency patients (congenital or acquired).
- •- Malignancies and patients receiving chemotherapy.
- •- Hypersensitivity to any active substances of the drug.
- •- Cases that received Ceftaroline prior to admission
研究者
相似试验
已完成
2 期
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure InfectionsBacterial InfectionNCT00633152Forest Laboratories150
已完成
1 期
A 2-part Study to Assess Local Tolerability, Safety and Pharmacokinetics of Ceftaroline in Healthy SubjectsHealthyNCT01577589Pfizer34
已完成
3 期
A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in AsiaCommunity-Acquired Bacterial PneumoniaLung Infection of Individual Not Recently HospitalizedNCT01371838Pfizer848
已完成
4 期
Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus AureusInfectionsNCT01645735Forest Laboratories49
进行中（未招募）
不适用
Study of Blood Levels of Ceftaroline fosamil in Children who arereceiving anitbiotic Therapy in the HospitalPharmacokinetics of a Single Dose of Ceftarolinefosamil in Children Ages Birth to Younger Than 12Years With Suspected or Confirmed InfectionMedDRA version: 14.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-002198-44-Outside-EU/EEACerexa, Inc. (subsidary of Forest Laboratories)56